Guangzhou Women And Children's Medical Center
Clinical trials sponsored by Guangzhou Women And Children's Medical Center, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- One-shot gene therapy aims to tame rett syndrome in young girls Results expected Oct 2026 (estimated)
- New drug YOLT-204 aims to reduce transfusions in blood disorders Results expected Apr 2027 (estimated)
-
One-shot gene therapy aims to tame rett syndrome in young girls
Disease control OngoingThis early-phase trial tests a single injection of AAV-MECP2 gene therapy into the spinal fluid of 8 girls aged 4-10 with Rett syndrome, a severe neurodevelopmental disorder. The goal is to see if the treatment is safe and can reduce disease severity. The study is not yet recruit…
Early phase 1 • Sponsor: Guangzhou Women and Children's Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Robotic vs. endoscopic: which biopsy method is more accurate for breast cancer?
Knowledge-focused OngoingThis study looks back at medical records of 150 women with breast cancer to compare two minimally invasive ways of checking whether cancer has spread to lymph nodes under the arm: robotic-assisted and endoscopic-assisted sentinel lymph node biopsy. The goal is to see which method…
Sponsor: Guangzhou Women and Children's Medical Center • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Robot vs scope: which minimally invasive surgery spares more nerves in breast cancer?
Knowledge-focused OngoingThis study compares two minimally invasive techniques for removing lymph nodes under the arm in people with breast cancer that has spread to those nodes. The goal is to see which method better protects nearby nerves, reduces side effects like numbness or pain, and improves recove…
Sponsor: Guangzhou Women and Children's Medical Center • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC